Non-Small Cell Lung Cancer — Year in Review Series on Relevant New Datasets and Advances in Therapeutic Targets Beyond EGFR

Featuring perspectives from Dr John V Heymach and Dr Maurice Pérol, including the following topics:

• Introduction: Relative Impact of Targeted Treatment (00:00)
• HER2 Alterations (8:04)
• KRAS Mutations (24:25)
• MET Overexpression (30:34)
• ALK Fusions (32:34)
• ROS1 Fusions (42:36)
• RET Fusions (52:00)

CME information and select publications